J.NasirK.et al (2021)
Allergy screening before first injection is critical
Step 3: Choose Your Injection Site The most common sites for self-administered b12 injections are the upper arm, thigh, or buttocks
Neutropenia and thrombocytopenia were also mainly reported in ICF syndrome type 1 but also in Rubinstein-Taybi syndrome type 1 and type 2, Kabuki syndrome type 1, MRAD 32 syndrome, and DYT28 syndrome, while pancytopenia and leukopenia were reported once in Sotos syndrome, ICF syndrome type 1, Kabuki syndrome type 1, and Rubinstein-Taybi syndrome type 2 patients (71, 77, 79, 109, 110, 126128, 148, 151, 154, 162) ( Figure 6A )
Most patients tolerating both well benefit from continuing 500 mg daily carnitine through their entire tirzepatide course